Review summary
Teaching objective: Treating tobacco dependence in a man who has already had a smoking-related cancer, without judgment: primary care for a 74-year-old physician and writer, seven years after a partial maxillectomy for squamous cell carcinoma of the palate, who still smokes about twenty cigars a day after many failed attempts to stop. The episode covers an assessment of readiness that does not blame him; starting varenicline before he is ready to set a quit date and adding combination nicotine replacement (ATS 2020, USPSTF 2021), with the point that cigars count; behavioral support; the risk of second primary cancers; head and neck cancer survivorship (NCCN, ACS 2016): yearly examination after five years, imaging only for symptoms or as screening supports, and lung cancer screening eligibility when the history is of cigars rather than cigarettes; maxillofacial prosthodontic care of the obturator, with speech, swallowing and dental care; nutrition and weight; and chronic pain managed without long-term opioids (CDC 2022). There is no radiation in the synthetic history, so there is no osteoradionecrosis risk.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| May 6, 1856 | Born in Freiberg, Moravia. | CLM-0001 |
| 1884 | Published On Coca after experimenting with cocaine himself. | CLM-0002 |
| 1894 | Irregular heartbeat attributed to smoking by his physician friend; failed attempts to stop smoking. | CLM-0005, CLM-0003, CLM-0004 |
| 1923 | Squamous cell carcinoma of the palate: excision in April and radiation, then a radical operation by Hans Pichler with an obturator; kept smoking. | CLM-0006, CLM-0007, CLM-0009 |
| 1929 | At 73, after a heart illness, stopped smoking for 23 days. | CLM-0010 |
| June 6, 1938 | Arrived in London as a refugee after fleeing Vienna. | CLM-0012 |
| September 23, 1939 | Died in London after more than thirty operations and procedures over sixteen years. | CLM-0013, CLM-0008, CLM-0011 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Sigmund Freud was born Sigismund Schlomo Freud on May 6, 1856, in Freiberg, Moravia, now in the Czech Republic; in 1860 his family settled in Vienna. | confirmed | Sigmund Freud: Conflict & Culture. Section One: Formative Years and the Founding of Psychoanalysis supports Sigmund Freud supports HISTMED Master Roster v3 context |
| D | In the 1880s he experimented with cocaine himself, praised it in his paper On Coca (1884), and urged others to use it before he realized it could be addictive. History only; the modern episode records no current drug use. |
confirmed | Sigmund Freud: Conflict & Culture. Section One: Formative Years and the Founding of Psychoanalysis supports Klein C. 10 Things You May Not Know About Sigmund Freud supports |
| D | According to his personal physician's account, as summarized in a 2019 review, he still used cocaine regularly in the 1890s. History only, recorded without detail. |
probable | Trimarchi M, Bertazzoni G, Bussi M. The disease of Sigmund Freud: oral cancer or cocaine-induced lesion? Eur Arch Otorhinolaryngol 2019;276(1):263-265 (PMID 30328499) supports |
| D | He began smoking in his twenties, first cigarettes and then cigars, following the example of his father, and often smoked about twenty cigars a day; his biographer described it as an addiction rather than a habit. The anchor for the synthetic tobacco use disorder; recorded without judgment. |
confirmed | Davies B. Freud and his Cigars supports Klein C. 10 Things You May Not Know About Sigmund Freud supports Adeyemo WL. Sigmund Freud: smoking habit, oral cancer and euthanasia. Niger J Med 2004;13(2):189-195 (PMID 15293843) supports Brecher EM and the Editors of Consumer Reports. The Consumers Union Report on Licit and Illicit Drugs, Chapter 24: The case of Dr. Sigmund Freud supports |
| D | In 1894, at 38, his friend the physician Wilhelm Fliess attributed his irregular heartbeat to smoking and told him to stop. He tried repeatedly and failed: one attempt ended within seven weeks, and a later one lasted fourteen months before he started again, describing the abstinence as torture. Anchors the history of cardiac symptoms attributed to nicotine and of failed quit attempts, which the modern episode treats as normal for nicotine dependence. |
confirmed | Brecher EM and the Editors of Consumer Reports. The Consumers Union Report on Licit and Illicit Drugs, Chapter 24: The case of Dr. Sigmund Freud supports |
| D | In 1923, at 67, he was diagnosed with cancer of the right upper jaw and palate, a squamous cell carcinoma; a first excision in April 1923 was followed by radiation treatment. The anchor for the synthetic survivorship episode. |
confirmed | Adeyemo WL. Sigmund Freud: smoking habit, oral cancer and euthanasia. Niger J Med 2004;13(2):189-195 (PMID 15293843) supports Benmoussa N, Charlier P, Rebibo JD. Historical Vignette: Attempted treatment of Sigmund Freud's oral squamous cell carcinoma by vasectomy (Steinach Operation) in 1923. Andrology 2020;8(3):688-690 (PMID 31705580) supports Freud's mouth prosthesis, made by Varaztad Kazanjian (Freud Museum London) supports |
| D | Later in 1923 the oral surgeon Hans Pichler performed a radical operation that removed part of the upper jaw and soft palate, and made the obturator prosthesis that closed the defect; Freud called it "the monster." Pichler provided most of his later prosthetic care. The anchor for the maxillectomy defect and obturator in the modern episode. |
confirmed | Davenport JC. The prosthetic care of Sigmund Freud. Br Dent J 1992;172(5):205-207 (PMID 1543636) supports Freud's mouth prosthesis, made by Varaztad Kazanjian (Freud Museum London) supports Tainmont J. Sigmund Freud's physicians and "the monster". B-ENT 2007;3(1):49-60 (PMID 17451128) supports |
| D | Over the sixteen years after the diagnosis he had more than thirty operations and procedures (33 or 34 are reported), radiation treatment, and constant pain from his mouth. History through his last years. |
confirmed | Adeyemo WL. Sigmund Freud: smoking habit, oral cancer and euthanasia. Niger J Med 2004;13(2):189-195 (PMID 15293843) supports Klein C. 10 Things You May Not Know About Sigmund Freud supports Trimarchi M, Bertazzoni G, Bussi M. The disease of Sigmund Freud: oral cancer or cocaine-induced lesion? Eur Arch Otorhinolaryngol 2019;276(1):263-265 (PMID 30328499) supports Brecher EM and the Editors of Consumer Reports. The Consumers Union Report on Licit and Illicit Drugs, Chapter 24: The case of Dr. Sigmund Freud supports |
| D | He kept smoking cigars after the cancer was diagnosed and refused to give them up. Anchors continued smoking after a smoking-related cancer, treated in the modern episode without blame. |
confirmed | Davies B. Freud and his Cigars supports Adeyemo WL. Sigmund Freud: smoking habit, oral cancer and euthanasia. Niger J Med 2004;13(2):189-195 (PMID 15293843) supports Klein C. 10 Things You May Not Know About Sigmund Freud supports |
| D | At 73, after a heart illness, he stopped smoking for 23 days and then gradually started again. The most recent quit attempt before the index visit. |
confirmed | Brecher EM and the Editors of Consumer Reports. The Consumers Union Report on Licit and Illicit Drugs, Chapter 24: The case of Dr. Sigmund Freud supports |
| R | One retrospective analysis has proposed that his destructive palatal disease might have been a cocaine-induced midline lesion rather than cancer; most accounts and his medical records describe a squamous cell carcinoma caused mainly by smoking. Not used in the modern episode, which follows the documented diagnosis. |
disputed | Trimarchi M, Bertazzoni G, Bussi M. The disease of Sigmund Freud: oral cancer or cocaine-induced lesion? Eur Arch Otorhinolaryngol 2019;276(1):263-265 (PMID 30328499) supports Adeyemo WL. Sigmund Freud: smoking habit, oral cancer and euthanasia. Niger J Med 2004;13(2):189-195 (PMID 15293843) disputes Davenport JC. The prosthetic care of Sigmund Freud. Br Dent J 1992;172(5):205-207 (PMID 1543636) disputes |
| D | After the Nazi annexation of Austria in 1938 he was forced to flee Vienna; he arrived in London as a refugee on June 6, 1938, and spent the last year of his life there. History after the modern episode. |
confirmed | Sigmund Freud supports Freud's Death Bed supports |
| D | He died in London on September 23, 1939, at 83, after his physician Max Schur, at his request, gave him morphine. History only, recorded in one plain sentence. |
confirmed | Freud's Death Bed supports Klein C. 10 Things You May Not Know About Sigmund Freud supports McCue JD, Cohen LM. Freud's physician-assisted death. Arch Intern Med 1999;159(14):1521-1525 (PMID 10421274) supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smoking | active | confirmed | both_with_link | CLM-0004, CLM-0009 |
| S | Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillance | active | confirmed | both_with_link | CLM-0006, CLM-0007 |
| S | Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorly | active | confirmed | active | CLM-0007 |
| S | Hypernasal speech and nasal leakage of liquids from a poorly sealing obturator | resolved | confirmed | active | CLM-0007 |
| S | Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubs | active | confirmed | active | CLM-0008 |
| S | Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smoking | active | confirmed | active | |
| S | Weight loss of 4 kg in six months from painful chewing and leakage, with a low albumin | resolved | confirmed | active | |
| S | Candida stomatitis of the palate and defect under the new obturator; treated with nystatin and prosthesis hygiene; resolved | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-06-01 | Hemoglobin [Mass/volume] in Blood | 13.2 g/dL (low) Reference 13.5-17.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-06-01 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 93 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-06-01 | Platelets [#/volume] in Blood by Automated count | 252 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-06-01 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-06-01 | Potassium [Moles/volume] in Serum or Plasma | 4.3 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-06-01 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-06-01 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 83 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-06-01 | Glucose [Mass/volume] in Serum or Plasma | 91 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-06-01 | Albumin [Mass/volume] in Serum or Plasma | 3.4 g/dL (low) Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 2026-06-01 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 2026-06-01 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5% Reference 4-5.6% |
http://loinc.org · 4548-4 |
| S | 2026-06-01 | Cholesterol [Mass/volume] in Serum or Plasma | 204 mg/dL (high) Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-06-01 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 126 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-06-01 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-06-01 | Triglyceride [Mass/volume] in Serum or Plasma | 170 mg/dL (high) Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-06-01 | Pain severity in the past week - 0-10 numeric rating [Reported] | 6 | http://loinc.org · 75893-8 |
| S | 2026-06-01 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 2026-06-15 | Pain severity in the past week - 0-10 numeric rating [Reported] | 6 | http://loinc.org · 75893-8 |
| S | 2026-07-13 | Pain severity in the past week - 0-10 numeric rating [Reported] | 4 | http://loinc.org · 75893-8 |
| S | 2026-08-24 | Albumin [Mass/volume] in Serum or Plasma | 3.7 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 2026-08-24 | Pain severity in the past week - 0-10 numeric rating [Reported] | 3 | http://loinc.org · 75893-8 |
| S | 2026-10-26 | Hemoglobin [Mass/volume] in Blood | 13.8 g/dL Reference 13.5-17.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-10-26 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 92 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-10-26 | Albumin [Mass/volume] in Serum or Plasma | 3.9 g/dL Reference 3.5-5 g/dL |
http://loinc.org · 1751-7 |
| S | 2026-10-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-10-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 81 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-10-26 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 25 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 2026-10-26 | Pain severity in the past week - 0-10 numeric rating [Reported] | 2 | http://loinc.org · 75893-8 |
| S | 2026-09-14 | Pain severity in the past week - 0-10 numeric rating [Reported] | 4 | http://loinc.org · 75893-8 |
| S | 2026-09-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-09-28 | Total score [Mini-Cog] | 5 | http://loinc.org · 72233-0 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-06-01 | Body height | 172 cm | 8302-2 | S |
| 2026-06-01 | Body weight | 58.4 kg | 29463-7 | S |
| 2026-06-01 | Body mass index (BMI) [Ratio] | 19.7 kg/m2 | 39156-5 | S |
| 2026-06-01 | Systolic blood pressure | 138 mm[Hg] | 8480-6 | S |
| 2026-06-01 | Diastolic blood pressure | 82 mm[Hg] | 8462-4 | S |
| 2026-06-01 | Heart rate | 80 /min | 8867-4 | S |
| 2026-06-01 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-06-01 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 2026-06-15 | Body height | 172 cm | 8302-2 | S |
| 2026-06-15 | Body weight | 58.2 kg | 29463-7 | S |
| 2026-06-15 | Body mass index (BMI) [Ratio] | 19.7 kg/m2 | 39156-5 | S |
| 2026-06-15 | Systolic blood pressure | 136 mm[Hg] | 8480-6 | S |
| 2026-06-15 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-06-15 | Heart rate | 78 /min | 8867-4 | S |
| 2026-06-15 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-06-15 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 2026-07-13 | Body height | 172 cm | 8302-2 | S |
| 2026-07-13 | Body weight | 58.9 kg | 29463-7 | S |
| 2026-07-13 | Body mass index (BMI) [Ratio] | 19.9 kg/m2 | 39156-5 | S |
| 2026-07-13 | Systolic blood pressure | 134 mm[Hg] | 8480-6 | S |
| 2026-07-13 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-07-13 | Heart rate | 76 /min | 8867-4 | S |
| 2026-07-13 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-07-13 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 2026-08-24 | Body height | 172 cm | 8302-2 | S |
| 2026-08-24 | Body weight | 59.8 kg | 29463-7 | S |
| 2026-08-24 | Body mass index (BMI) [Ratio] | 20.2 kg/m2 | 39156-5 | S |
| 2026-08-24 | Systolic blood pressure | 132 mm[Hg] | 8480-6 | S |
| 2026-08-24 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-08-24 | Heart rate | 70 /min | 8867-4 | S |
| 2026-08-24 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-08-24 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-10-26 | Body height | 172 cm | 8302-2 | S |
| 2026-10-26 | Body weight | 60.6 kg | 29463-7 | S |
| 2026-10-26 | Body mass index (BMI) [Ratio] | 20.5 kg/m2 | 39156-5 | S |
| 2026-10-26 | Systolic blood pressure | 130 mm[Hg] | 8480-6 | S |
| 2026-10-26 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-10-26 | Heart rate | 68 /min | 8867-4 | S |
| 2026-10-26 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-10-26 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-10-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-09-14 | Body height | 172 cm | 8302-2 | S |
| 2026-09-14 | Body weight | 60 kg | 29463-7 | S |
| 2026-09-14 | Body mass index (BMI) [Ratio] | 20.3 kg/m2 | 39156-5 | S |
| 2026-09-14 | Systolic blood pressure | 132 mm[Hg] | 8480-6 | S |
| 2026-09-14 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-09-14 | Heart rate | 72 /min | 8867-4 | S |
| 2026-09-14 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-14 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-09-28 | Body height | 172 cm | 8302-2 | S |
| 2026-09-28 | Body weight | 60.2 kg | 29463-7 | S |
| 2026-09-28 | Body mass index (BMI) [Ratio] | 20.3 kg/m2 | 39156-5 | S |
| 2026-09-28 | Systolic blood pressure | 130 mm[Hg] | 8480-6 | S |
| 2026-09-28 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-09-28 | Heart rate | 70 /min | 8867-4 | S |
| 2026-09-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-28 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Physician who works as a psychotherapist and writer; sees patients in the mornings and writes in the afternoons and evenings
- S Tobacco: started with cigarettes in his twenties, then cigars; about twenty cigars a day for about fifty years, inhaling some of the smoke; first cigar within 30 minutes of waking; many attempts to stop, the longest about fourteen months; says cigars help him work
- S Alcohol: rarely, a glass of wine at dinner; no drug use now; experimented with cocaine as a young doctor and has used none for decades
- S Married; lives with his household in the city; walks daily
- S Eats soft foods because chewing hurts; liquids sometimes leak into his nose; meals take a long time
- S Strengths: his work and writing, a disciplined daily routine, intellectual curiosity, and long experience of living with the prosthesis
Functional status
- S Independent in all activities; speech is harder to understand when the obturator leaks, which tires him during long working days
Mental status
- S Alert, precise and ironic; speech hypernasal; mood steady; PHQ-2 1; no cognitive concerns
Allergies and medications
Allergies
- S No known allergy
Medications
- S Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days
- S Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks
- S Nicotine 21 mg/24 hours transdermal patch, one patch each morning from the quit date, for six weeks
- S Nicotine 14 mg/24 hours transdermal patch, one patch each morning for four weeks, then stop
- S Nicotine 4 mg oral lozenge, one lozenge as needed for cravings, up to 10 a day, dissolved on the side away from the obturator; gum avoided because it sticks to the prosthesis
- S Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site
- S Nystatin 100,000 units/mL oral suspension, 5 mL swished around the mouth and defect for as long as possible and then swallowed, four times daily with the obturator out, for 14 days
- S Atorvastatin 20 mg oral tablet, one tablet daily
Procedures and immunizations
Procedures
- S Chairside reline of the maxillary obturator with a soft tissue conditioner, and adjustment of the flange over a traumatic ulcer, by the maxillofacial prosthodontist
- S Fitting of a new definitive maxillary obturator prosthesis, made from impressions taken at six weeks
- S Advance care planning conversation, about 20 minutes
- S Low-dose CT of the chest for lung cancer screening, chosen by shared decision: Lung-RADS 2 (a 4 mm solid nodule in the right upper lobe), mild centrilobular emphysema and moderate coronary artery calcification; next screening in 12 months
- S Ultrasound of the abdominal aorta for one-time aneurysm screening: maximum diameter 2.7 cm, normal
Immunizations
- S 2026-09-28: Influenza vaccine, high-dose, this season
- S 2026-09-28: Pneumococcal conjugate vaccine (PCV20), one dose
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D 1884: Experimented with cocaine and wrote about it; later regular use reported in the 1890s (CLM-0002, CLM-0003)
- D 1894: Irregular heartbeat attributed by his physician to smoking, with failed attempts to stop (CLM-0005)
- D 1923: Squamous cell carcinoma of the palate: excision and radiation, then a radical operation removing part of the upper jaw and soft palate, with an obturator prosthesis (CLM-0006, CLM-0007)
- D 1929: Heart illness at 73, followed by 23 days without smoking (CLM-0010)
Family history
- D father: Smoked until his death at 81; cause of death not recorded in the cited source
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Stop smoking cigars completely, at a pace he chooses, using varenicline and nicotine replacement | 2026-10-26 | active | Twenty cigars a day to six by six weeks; no smoking since the quit date apart from one cigar in the second week; about fourteen weeks without smoking at five months |
| An obturator that seals and does not rub, so that speech is clear and liquids do not leak into his nose | 2026-08-24 | completed | Reline at two weeks; new definitive obturator fitted at twelve weeks; speech clear and no nasal leakage |
| Pain at 3 of 10 or less without opioids | 2026-10-26 | completed | Pain 6 to 2 of 10 on scheduled acetaminophen with a well-fitting obturator |
| Regain weight to at least 60 kg with a normal albumin | 2026-10-26 | completed | Weight 58.4 to 60.6 kg; albumin 3.4 to 3.9 g/dL |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Tobacco: a nonjudgmental assessment of readiness and of what cigars do for him; varenicline started now, before a quit date, with a plan to cut down and then stop; combination nicotine replacement (patch and lozenge) added from the quit date; cigars are counted like any other tobacco; weekly behavioral support by phone with the national quitline and in clinic; relapse treated as part of the process | completed | GL-ATS-TOB-2020, GL-USPSTF-TOB-2021 |
| Maxillofacial prosthodontics consultation for a worn, poorly sealing obturator with pain, hypernasal speech and nasal leakage, and for dental care | completed | GL-ACS-HNSURV-2016, GL-NCCN-HN-2026 |
| Head and neck cancer survivorship: yearly examination of the mouth, defect and neck by his head and neck surgeon (more than five years after treatment), self-examination of the mouth, prompt review of any sore, lump, bleeding or change that lasts two weeks, imaging only for symptoms, and counseling on the risk of second primary cancers of the mouth, throat, larynx, esophagus and lung, which stopping smoking lowers | completed | GL-NCCN-HN-2026, GL-ACS-HNSURV-2016 |
| Chronic pain: scheduled acetaminophen up to 3,000 mg a day, a well-fitting obturator, warm saline rinses, and no long-term opioids; the plan is reviewed at each visit with a pain score | completed | GL-CDC-OPIOID-2022, GL-ACS-HNSURV-2016 |
| Nutrition: dietitian advice on soft high-protein meals, oral nutrition supplements twice daily, weight at each visit and albumin rechecked | completed | GL-ACS-HNSURV-2016 |
| Prosthodontic care: chairside reline and flange adjustment now, a new definitive obturator, nightly cleaning and an overnight soak, high-fluoride toothpaste, dental cleaning every three months, nicotine lozenge rather than gum, and speech and swallowing therapy sessions with a speech-language pathologist after the reline | completed | GL-ACS-HNSURV-2016, GL-NCCN-HN-2026 |
| Cardiovascular risk: lipid panel and 10-year risk estimate; a statin discussed with him once the smoking plan is under way | completed | GL-USPSTF-STATIN-2022 |
Planned encounters
- 2026-06-01 — Establishing primary care seven years after maxillectomy for palatal cancer: about twenty cigars a day, a worn obturator, pain and weight loss (ENC-001)
- 2026-06-15 — Two-week review with the maxillofacial prosthodontics consultation: obturator reline, speech, swallowing and dental care; varenicline at full dose (ENC-002)
- 2026-07-13 — Six-week review: smoking down by two thirds, setting a quit date, pain and weight (ENC-003)
- 2026-08-24 — Twelve-week review: five weeks without smoking, the new obturator and survivorship surveillance (ENC-004)
- 2026-09-14 — Same-day sick visit for Candida stomatitis under the obturator (ENC-006, unscheduled)
- 2026-09-28 — Subsequent annual wellness visit (ENC-007)
- 2026-10-26 — Five-month review: abstinence, lung and aortic screening results, pain, weight and the survivorship plan (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Sick Visit
- Progress note 06 — Annual Wellness Visit, Subsequent
- Progress note 07 — Focused Visit (Care-plan review)
- Maxillofacial Prosthodontics referral
- Maxillofacial Prosthodontics consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Sick Visit (XML)
- Progress note 06 — Annual Wellness Visit, Subsequent (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Maxillofacial Prosthodontics referral (XML)
- Maxillofacial Prosthodontics consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check varenicline started before a quit date with combination nicotine replacement, the extended course, the lozenge with an obturator, the survivorship schedule more than five years after treatment, lung cancer screening chosen by shared decision for a cigar smoker, the pain plan without opioids, and the statin decision. |
| provenance review | not_started | Sources: Library of Congress exhibition, Freud Museum London (three pages), History.com, the Consumers Union report quoting Ernest Jones, and PubMed records of six articles (abstracts only). The biographies by Jones and by Schur were not read. The cocaine-lesion hypothesis is graded R and disputed. |
| safe messaging review | not_started | Cocaine use, tobacco dependence and his death are marked sensitive; his death is recorded once in one plain sentence; the modern episode treats continued smoking after cancer without blame. No living relative is named. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.